SwePub
Sök i SwePub databas

  form:Ext_t

Träfflista för sökning "WFRF:(Auvinen A) "

form:Search_simp_t: WFRF:(Auvinen A)

  • navigation:Result_t 41-50 navigation:of_t 152
hitlist:Modify_result_t
   
hitlist:Enumeration_thitlist:Reference_thitlist:Reference_picture_thitlist:Find_Mark_t
41.
  •  
42.
  •  
43.
  •  
44.
  • Hugosson, Jonas, 1955, et al. (creator_code:aut_t)
  • A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer
  • 2019
  • record:In_t: European Urology. - : Elsevier BV. - 0302-2838. ; 76:1, s. 43-51
  • swepub:Mat_article_t (swepub:level_refereed_t)abstract
    • Background: The European Randomized study of Screening for Prostate Cancer (ERSPC) has previously demonstrated that prostate-specific antigen (PSA) screening decreases prostate cancer (PCa) mortality. Objective: To determine whether PSA screening decreases PCa mortality for up to 16 yr and to assess results following adjustment for nonparticipation and the number of screening rounds attended. Design, setting, and participants: This multicentre population-based randomised screening trial was conducted in eight European countries. Report includes 182 160 men, followed up until 2014 (maximum of 16 yr), with a predefined core age group of 162 389 men (55-69 yr), selected from population registry. Outcome measurements and statistical analysis: The outcome was PCa mortality, also assessed with adjustment for nonparticipation and the number of screening rounds attended. Results and limitations: The rate ratio of PCa mortality was 0.80 (95% confidence interval [CI] 0.72-0.89, p < 0.001) at 16 yr. The difference in absolute PCa mortality increased from 0.14% at 13 yr to 0.18% at 16 yr. The number of men needed to be invited for screening to prevent one PCa death was 570 at 16 yr compared with 742 at 13 yr. The number needed to diagnose was reduced to 18 from 26 at 13 yr. Men with PCa detected during the first round had a higher prevalence of PSA >20 ng/ml (9.9% compared with 4.1% in the second round, p < 0.001) and higher PCa mortality (hazard ratio = 1.86, p < 0.001) than those detected subsequently. Conclusions: Findings corroborate earlier results that PSA screening significantly reduces PCa mortality, showing larger absolute benefit with longer follow-up and a reduction in excess incidence. Repeated screening may be important to reduce PCa mortality on a population level. Patient summary: In this report, we looked at the outcomes from prostate cancer in a large European population. We found that repeated screening reduces the risk of dying from prostate cancer. (C) 2019 Published by Elsevier B.V. on behalf of European Association of Urology.
  •  
45.
  •  
46.
  •  
47.
  •  
48.
  •  
49.
  •  
50.
  • Bechta, Sevostian, et al. (creator_code:aut_t)
  • Influence of corium oxidation on fission product release from molten pool
  • 2010
  • record:In_t: Nuclear Engineering and Design. - : Elsevier BV. - 0029-5493 .- 1872-759X. ; 240:5, s. 1229-1241
  • swepub:Mat_article_t (swepub:level_refereed_t)abstract
    • Qualitative and quantitative determination of the release of low-volatile fission products and core materialsfrom molten oxidic corium was investigated in the EVAN project under the auspices of ISTC. Theexperiments carried out in a cold crucible with induction heating and RASPLAV test facility are described.The results are discussed in terms of reactor application; in particular, pool configuration, melt oxidationkinetics, critical influence of melt surface temperature and oxidation index on the fission productrelease rate, aerosol particle composition and size distribution. The relevance of measured high releaseof Sr from the molten pool for the reactor application is highlighted. Comparisons of the experimentaldata with those from the COLIMA CA-U3 test and the VERCORS tests, as well as with predictions fromIVTANTHERMO and GEMINI/NUCLEA codes are made. Recommendations for further investigations areproposed following the major observations and discussions.
  •  
Skapa referenser, mejla, bekava och länka
  • navigation:Result_t 41-50 navigation:of_t 152
swepub:Mat_t
swepub:mat_article_t (142)
swepub:mat_conferencepaper_t (8)
swepub:mat_publicationother_t (1)
swepub:mat_researchreview_t (1)
swepub:Level_t
swepub:level_refereed_t (139)
swepub:level_scientificother_t (13)
swepub:Hitlist_author_t
Auvinen, A (91)
Feychting, M (32)
Johansen, C (32)
Giles, GG (28)
Brenner, H (23)
Easton, DF (23)
deldatabas:search_more_t
Lonn, S (21)
Dunning, AM (21)
Nordestgaard, BG (21)
Tynes, T (21)
Southey, MC (20)
Bojesen, SE (20)
Lubinski, J (20)
Wang, Q. (18)
Truong, T (18)
Haiman, CA (18)
Le Marchand, L (18)
Swerdlow, AJ (18)
Klæboe, L (18)
Schmidt, MK (17)
Schuz, J (17)
Hunter, DJ (17)
Gago-Dominguez, M. (17)
Salminen, T (17)
Zheng, W. (16)
Riboli, E. (16)
Mannermaa, A (16)
Kraft, P (16)
John, EM (16)
Castelao, JE (16)
Christensen, HC (15)
Czene, K (14)
Muir, K (14)
Chang-Claude, J (14)
Garcia-Closas, M (14)
Chanock, SJ (14)
Flyger, H (14)
Schleutker, J (14)
Schoemaker, MJ (14)
Claessens, F (14)
Kim, J. (13)
Kaaks, R. (13)
Dennis, J (13)
Hamann, U (13)
Andrulis, IL (13)
Jakubowska, A (13)
Cardis, E (13)
Khaw, KT (13)
Cybulski, C (13)
Chetrit, A (13)
deldatabas:search_less_t
swepub:Hitlist_uni_t
swepub_uni:ki_t (117)
swepub_uni:gu_t (17)
swepub_uni:uu_t (16)
swepub_uni:lu_t (14)
swepub_uni:umu_t (12)
swepub_uni:cth_t (6)
deldatabas:search_more_t
swepub_uni:kth_t (4)
swepub_uni:su_t (3)
swepub_uni:miun_t (2)
swepub_uni:oru_t (1)
deldatabas:search_less_t
hitlist:Language_t
language:Eng_t (152)
hitlist:HSV_t
hsv:Cat_3_t (32)
hsv:Cat_1_t (6)
hsv:Cat_2_t (6)

hitlist:Year_t

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt tools:Close_t

tools:Permalink_label_t